STAGE IIA PANCREATIC CANCER AJCC V8
Clinical trials for STAGE IIA PANCREATIC CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIA PANCREATIC CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIA PANCREATIC CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Sound waves could supercharge chemo against tough pancreatic cancer
Disease control OngoingThis study tests a new method called sonoporation, which uses ultrasound and tiny gas bubbles to help chemotherapy drugs get into cancer cells more effectively. About 120 adults with advanced pancreatic cancer will receive either standard chemotherapy alone or chemotherapy plus s…
Matched conditions: STAGE IIA PANCREATIC CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: Flemming Forsberg • Aim: Disease control
Last updated May 26, 2026 06:00 UTC
-
Promising combo targets pancreatic tumors before surgery
Disease control OngoingThis study tests whether giving a mix of chemotherapy (gemcitabine, nab-paclitaxel) and immunotherapy (durvalumab, oleclumab) before surgery can shrink pancreatic tumors and improve outcomes. It involves 13 adults with early-stage, removable pancreatic cancer. The goal is to see …
Matched conditions: STAGE IIA PANCREATIC CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 05:49 UTC
-
New drug cocktail aims to starve pancreatic tumors
Disease control OngoingThis early-phase study tests a combination of two drugs—calaspargase pegol-mknl and cobimetinib—in people with advanced pancreatic cancer that has spread. The goal is to find the safest dose and see if the combo can control the disease by cutting off the cancer cells' food supply…
Matched conditions: STAGE IIA PANCREATIC CANCER AJCC V8
Phase: PHASE1 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New drug combo shows promise for Hard-to-Treat pancreatic cancer
Disease control OngoingThis study tests whether a combination of two drugs, lenvatinib and pembrolizumab, can help control advanced pancreatic cancer that cannot be removed by surgery. About 28 adults whose cancer has not worsened after initial treatment will receive these drugs as maintenance therapy.…
Matched conditions: STAGE IIA PANCREATIC CANCER AJCC V8
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 22, 2026 13:50 UTC